Is UroGen Pharma Ltd. technically bullish or bearish?
As of September 19, 2025, UroGen Pharma Ltd. shows a mildly bullish technical trend with strong MACD and KST indicators, despite mixed signals from Dow Theory, and has outperformed the S&P 500 year-to-date and over one year, though it has underperformed over the last five and ten years.
As of 19 September 2025, the technical trend for UroGen Pharma Ltd. has changed from bullish to mildly bullish. The weekly MACD and KST indicators remain bullish, while the monthly MACD is also bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames. However, the Dow Theory shows a mildly bearish signal on the weekly chart, contrasting with a mildly bullish monthly outlook. The daily moving averages are mildly bullish, suggesting some short-term support.In terms of performance, UroGen has outperformed the S&P 500 year-to-date with a return of 68.54% compared to the S&P 500's 13.31%, and over one year, it has returned 29.60% versus the S&P 500's 16.64%. However, over the last five and ten years, UroGen has underperformed significantly against the benchmark. Overall, the current technical stance is mildly bullish, driven by strong MACD and KST indicators, despite some mixed signals from Dow Theory.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
